ClinicalTrials.Veeva

Menu

A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander (CHILD)

Northwell Health logo

Northwell Health

Status

Completed

Conditions

Autism Spectrum Disorder
Wandering Behavior

Treatments

Device: Electronic Tracking Device

Study type

Interventional

Funder types

Other

Identifiers

NCT03814902
18-0314_A

Details and patient eligibility

About

This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasibility of all study procedures and the acceptability of the intervention will be evaluated.

Full description

Wandering, or elopement, is a life-threatening behavior that has been reported to occur in a third of all children with autism spectrum disorders (ASD). Wearable electronic tracking devices (ETDs) that are able to pinpoint a child's location have emerged as an appealing intervention for families concerned about wandering risk. However, the impact of ETD use on the families of children who wander has never been studied prospectively. In this pilot study, parents will be provided with a commercially-available ETD to use for their child with ASD for 6 weeks. Preliminary data will be obtained to evaluate the impact of ETD use on the strain experienced by families due to their child's wandering behavior. The feasibility of all study procedures will be assessed in preparation for a larger subsequent trial.

Enrollment

31 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years of age
  • Parent of a child between the ages of 4 and 17 who currently has autism spectrum disorder (ASD), was diagnosed with ASD by a professional, and has wandered at least once in the preceding 3 months
  • Currently lives in the United States
  • Currently lives with child with ASD
  • Has been living with child with ASD for at least 6 months
  • Has reliable internet access to allow for completion of online questionnaires

Exclusion criteria

Current or past use of any electronic tracking device to address wandering behavior in the child with ASD

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

31 participants in 1 patient group

Electronic Tracking Device
Experimental group
Description:
Participants will be given a wearable electronic tracking device (ETD) to use for their child with autism spectrum disorder (ASD) for 6 weeks.
Treatment:
Device: Electronic Tracking Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems